Zobrazeno 1 - 10
of 137
pro vyhledávání: '"John A Ellerton"'
Autor:
Thompson, David
Publikováno v:
The Oxford Dictionary of the Christian Church, 4 ed., 2022.
Externí odkaz:
http://www.oxfordreference.com/view/10.1093/acref/9780199642465.001.0001/acref-9780199642465-e-2369
Publikováno v:
The Concise Oxford Dictionary of the Christian Church, 3 ed., 2014.
Externí odkaz:
http://www.oxfordreference.com/view/10.1093/acref/9780199659623.001.0001/acref-9780199659623-e-1903
Autor:
Cross, F. L, Livingstone, E. A
Publikováno v:
The Oxford Dictionary of the Christian Church, 3 rev. ed., 2009.
Externí odkaz:
http://www.oxfordreference.com/view/10.1093/acref/9780192802903.001.0001/acref-9780192802903-e-2297
Autor:
James L Gulley, Manish R Patel, Keun-Wook Lee, Luc Dirix, Mary Ruisi, Jeffrey R Infante, Patrick Schöffski, Alain Ravaud, Ding Wang, Andrea B Apolo, John A Ellerton, Manish Agrawal, Michael S Gordon, Raid Aljumaily, Theodore Gourdin, Matthew H Taylor, Juliane Manitz, Gregory Pennock
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Background Anti-programmed cell death ligand 1 (PD-L1)/programmed cell death 1 antibodies have shown clinical activity in platinum-treated metastatic urothelial carcinoma, resulting in regulatory approval of several agents, including avelumab (anti-P
Externí odkaz:
https://doaj.org/article/8cbddaa59a7041aa874038d1754428b8
Publikováno v:
The Musical Times and Singing Class Circular, 1870 Dec 01. 14(334), 716-716.
Externí odkaz:
https://www.jstor.org/stable/3351617
Autor:
Young Kwang Chae, Megan Othus, Sandip Pravin Patel, Kelly J. Wilkinson, Emily M. Whitman-Purves, Jayanthi Lea, John M. Schallenkamp, Nabil Adra, Leonard J. Appleman, Mitchell Alden, Jessica Thomes Pepin, John A. Ellerton, Andrew Poklepovic, Adam Walter, Murtuza M. Rampurwala, William R. Robinson, Liam Il-Young Chung, Christine M. McLeod, Helen X. Chen, Elad Sharon, Howard Streicher, Christopher W. Ryan, Charles D. Blanke, Razelle Kurzrock
Publikováno v:
Cancer Research. 83:CT161-CT161
Background: Dual checkpoint inhibition with Anti-PD-1 and anti-CTLA4 checkpoint inhibitors have proven to be effective in several malignancies but their potential role in numerous rare solid cancers is yet to be established. This study presents the f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::396ff6e0b659a18e2144b298b743ee25
https://doi.org/10.1158/1538-7445.am2023-ct161
https://doi.org/10.1158/1538-7445.am2023-ct161
Autor:
John A. Ellerton, Mathieu Pasquier, Peter Paal, Giacomo Strapazzon, Tomasz Darocha, Hermann Brugger
Publikováno v:
Anesthesia and analgesia. 135(5)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b422d20955b1a5dad1b28799fb2f029d
https://pubmed.ncbi.nlm.nih.gov/36269997
https://pubmed.ncbi.nlm.nih.gov/36269997
Autor:
Jeffrey R. Infante, Patrick Schöffski, Michael S. Gordon, Alain Ravaud, Manish Agrawal, John Allan Ellerton, Juliane Manitz, Manish R. Patel, Mary Ruisi, Andrea B. Apolo, Matthew H. Taylor, Luc Dirix, Ding Wang, Keun Wook Lee, Raid Aljumaily, Gregory Pennock, Theodore Gourdin, J.L. Gulley
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Journal for Immunotherapy of Cancer
Journal for Immunotherapy of Cancer
BackgroundAnti-programmed cell death ligand 1 (PD-L1)/programmed cell death 1 antibodies have shown clinical activity in platinum-treated metastatic urothelial carcinoma, resulting in regulatory approval of several agents, including avelumab (anti-PD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b5b9fa96546aac04d870e76ec58182c
https://jitc.bmj.com/content/8/2/e001246.full
https://jitc.bmj.com/content/8/2/e001246.full
Publikováno v:
Dwight's Journal of Music; 4/19/1873, Vol. 33 Issue 1, p4-5, 2p
Autor:
Galit Rosen, Andrea B. Apolo, Manish R. Patel, Mathew Taylor, Junyuan Xiong, Michael Gordon, Keun Wook Lee, Manish Agrawal, James L. Gulley, Carolyn D. Britten, Ding Wang, Jeffrey R. Infante, John Allan Ellerton, Alain Ravaud, Luc Dirix, Patrick Schöffski, Raid Aljumaily, Arnold B. Gelb
Publikováno v:
Lancet Oncol
Translational Cancer Research
Translational Cancer Research
Summary Background The approval of anti-programmed death ligand 1 (PD-L1) and anti-programmed death 1 agents has expanded treatment options for patients with locally advanced or metastatic urothelial carcinoma. Avelumab, a human monoclonal anti-PD-L1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b17458409e554d7d7e53d1e16ee0c45
https://europepmc.org/articles/PMC7984727/
https://europepmc.org/articles/PMC7984727/
